載入...
A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies
INTRODUCTION: The clinical efficacy of trastuzumab and taxanes is at least partly related to their ability to mediate or promote antitumor immune responses. On these grounds, a careful analysis of basal immune profile may be capital to dissect the heterogeneity of clinical responses to these drugs i...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2011
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3326559/ https://ncbi.nlm.nih.gov/pubmed/22112244 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr3060 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|